International Journal of Clinical Science and Medical Research

Idiopathic choroidal neovascularization (ICNV) is a rare but potentially vision-threatening condition occurring in patients under 50 years of age. Its etiology remains unclear, and the disease often affects the macular region, leading to severe visual impairment if untreated. We report two cases of ICNV in young adults successfully managed with intravitreal anti-VEGF injections. These cases illustrate the diagnostic approach and highlight the favorable prognosis achievable with early treatment.

Idiopathic choroidal neovascularization, anti-VEGF, OCT, fluorescein angiography, young adults.

1. Cohen SY, et al. Idiopathic choroidal neovascularization in young adults: natural course and treatment outcomes. Retina. 2021;41(2):233–242.
2. Spaide RF, Yannuzzi LA. Idiopathic subfoveal choroidal neovascularization. Am J Ophthalmol. 2020;215:180–190.
3. Chan WM, et al. Intravitreal anti-VEGF therapy for idiopathic choroidal neovascularization. Br J Ophthalmol. 2022;106(5):625–631.
4. Kim RY, et al. Epidemiology of choroidal neovascularization in young adults. Ophthalmologica. 2023;246(3):205–212.
5. Querques G, et al. Pathophysiology of idiopathic choroidal neovascularization. Prog Retin Eye Res. 2021;84:100963.
6. Lim JI, et al. Fluorescein angiography findings in idiopathic CNV. Eye (Lond). 2020;34(8):1435–1443.
7. Coscas F, et al. OCT angiography in idiopathic CNV: diagnostic contribution. Ophthalmol Retina. 2022;6(1):57–66.
8. Souied EH, et al. Photodynamic therapy for idiopathic CNV: long-term results. Retina. 2020;40(4):662–670.
9. Chen Z, et al. Comparative efficacy of anti-VEGF agents in idiopathic CNV. Eye. 2023;37(1):105–114.
10. Ahn SJ, et al. Recurrence rate and visual prognosis in idiopathic CNV after anti-VEGF treatment. Retina. 2022;42(6):1072–1080.
11. Wu L, et al. Long-term outcomes of anti-VEGF in ICNV: 5-year follow-up. Graefes Arch Clin Exp Ophthalmol. 2023;261(2):411–421.
12. Lumbroso B, et al. Bilateral idiopathic CNV: OCT angiography findings and outcomes. Am J Ophthalmol. 2021;230:181–190.